logo

For the Inventor, By the Inventor

Fontenay-sous-Bois, France

Don Pierre Giudicelli

USPTO Granted Patents = 24

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 202(Granted Patents)


Company Filing History:

goldMedal24 out of 252 
 
Synthelabo
 patents

Years Active: 1976-1983

Loading Chart...
24 patents (USPTO):Explore Patents
1. 4400394 - Benzylidene derivatives (1983-08-23),
2. 4311708 - Phenol ethers (1982-01-19),
3. 4252984 - Phenol ethers (1981-02-24),
4. 4190657 - Naphthyridine derivatives (1980-02-26),
5. 4189495 - 2-Methoxy-benzamide derivatives (1980-02-19),
6. 4172143 - 2-Methoxy-benzamide derivatives (1979-10-23),
7. 4158060 - 2-Methoxy-benzamide derivatives (1979-06-12),
8. 4148923 - 1-(3'-Trifluoromethylthiophenyl)-2-ethylaminopropane pharmaceutical (1979-04-10),
9. 4129598 - Phenylethylamine derivatives (1978-12-12),
10. 4094992 - Benzylidene derivatives (1978-06-13),
11. 4067996 - Phenylacetic acid derivatives (1978-01-10),
12. 4044132 - Substituted piperazine derivative, its preparation and anorexia (1977-08-23),
13. 4031094 - N-meta-trifluoromethylpiperazines (1977-06-21),
14. 4021567 - 2-Methoxy-benzamide derivatives (1977-05-03),
15. 4021559 - Method for treating sickle-cell anemia (1977-05-03),

Title: Innovations and Contributions of Don Pierre Giudicelli

Introduction

Don Pierre Giudicelli is a prominent inventor based in Fontenay-sous-Bois, France. With a remarkable portfolio of 24 patents, he has made significant contributions to the fields of chemistry and pharmacology. His innovative work is particularly noted in the development of new pharmaceutical compounds aimed at treating neurological conditions.

Latest Patents

Among his most recent patents are advancements related to benzylidene derivatives, which involve specific compounds that demonstrate promising applications in the treatment of epilepsy. The structural formula reveals unique substitutions on the benzylidene ring, indicating a diverse potential for therapeutic use. Additionally, his patents encompass phenol ethers that further expand the library of compounds available for medical applications, showcasing a commitment to addressing complex health issues through innovative chemical solutions.

Career Highlights

Don Pierre Giudicelli has had an impactful career at Synthelabo, where he has been integral to research and development projects. His work has not only benefited the company but also contributed to the wider scientific community with practical applications in medicine. The pursuit of novel compounds underlines his dedication to innovation and improving patient outcomes in various health conditions.

Collaborations

Throughout his career, Don Pierre has collaborated with esteemed colleagues such as Henry Najer and Philippe Michel Manoury. These partnerships have played a crucial role in driving forward various research initiatives and enhancing the scope of his innovative projects.

Conclusion

Overall, Don Pierre Giudicelli's extensive array of patents and his collaborations with other experts reflect a deep commitment to innovation in the pharmaceutical industry. His continued focus on developing new chemical compounds highlights the importance of creativity and perseverance in the field of scientific research, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…